Farhad Zaker

597 total citations
51 papers, 448 citations indexed

About

Farhad Zaker is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Farhad Zaker has authored 51 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 17 papers in Molecular Biology and 15 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Farhad Zaker's work include Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (15 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Farhad Zaker is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Acute Lymphoblastic Leukemia research (15 papers) and Chronic Myeloid Leukemia Treatments (11 papers). Farhad Zaker collaborates with scholars based in Iran, United States and Sweden. Farhad Zaker's co-authors include Ahmad Kazemi, Akbar Dorgalaleh, Vahid Pazhakh, Shadi Tabibian, Farzaneh Atashrazm, Soudabeh Hosseini, Majid Safa, Majid Naderi, Morteza Shamsizadeh and Mohammad Hossein Mohammadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomedicine & Pharmacotherapy and Cytokine.

In The Last Decade

Farhad Zaker

47 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farhad Zaker Iran 13 222 126 79 78 76 51 448
Guanghua Zhu China 11 89 0.4× 59 0.5× 25 0.3× 48 0.6× 29 0.4× 37 326
Richard Coffey United States 8 360 1.6× 116 0.9× 252 3.2× 114 1.5× 11 0.1× 12 657
Mohamed El‐Shanshory Egypt 11 99 0.4× 73 0.6× 106 1.3× 51 0.7× 35 0.5× 41 399
Suzanne Monjanel‐Mouterde France 13 58 0.3× 55 0.4× 37 0.5× 92 1.2× 101 1.3× 22 408
Romélia Pinheiro Gonçalves Brazil 12 205 0.9× 58 0.5× 205 2.6× 17 0.2× 47 0.6× 38 402
Maciej Niedźwiecki Poland 11 103 0.5× 76 0.6× 14 0.2× 36 0.5× 81 1.1× 31 352
Geetika Srivastava United States 9 107 0.5× 144 1.1× 20 0.3× 108 1.4× 19 0.3× 31 411
Željka Večerić‐Haler Slovenia 10 19 0.1× 107 0.8× 46 0.6× 42 0.5× 41 0.5× 24 433
Han Zhu China 12 103 0.5× 175 1.4× 26 0.3× 29 0.4× 24 0.3× 29 386
P. David Sadowitz United States 10 53 0.2× 70 0.6× 20 0.3× 30 0.4× 18 0.2× 20 376

Countries citing papers authored by Farhad Zaker

Since Specialization
Citations

This map shows the geographic impact of Farhad Zaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Zaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Zaker more than expected).

Fields of papers citing papers by Farhad Zaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhad Zaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Zaker. The network helps show where Farhad Zaker may publish in the future.

Co-authorship network of co-authors of Farhad Zaker

This figure shows the co-authorship network connecting the top 25 collaborators of Farhad Zaker. A scholar is included among the top collaborators of Farhad Zaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhad Zaker. Farhad Zaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zaker, Farhad, et al.. (2023). Lower Levels of TET2 Gene Expression, with a Higher Level of TET2 Promoter Methylation in Patients with AML; Evidence for the Role of Aberrant Methylation in AML Pathogenesis. Indian Journal of Hematology and Blood Transfusion. 40(1). 52–60. 1 indexed citations
3.
Chegeni, Rouzbeh, et al.. (2023). Ultrasensitive quantitation of FLT3-ITD mutation in patients with acute myeloid leukemia using ddPCR. Molecular Biology Reports. 50(7). 6097–6105. 2 indexed citations
4.
Barati, Mahmood, et al.. (2022). Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia. Molecular Biology Reports. 49(8). 7849–7862. 3 indexed citations
5.
Dorgalaleh, Akbar, et al.. (2020). How to Assess Founder Effect in Patients with Congenital Factor XIII Deficiency. International Journal of Hematology-Oncology and Stem Cell Research. 14(4). 265–273. 1 indexed citations
6.
Atyabi, Nahid, et al.. (2019). The Role of MicroRNA-429 in E2F3 Expression in Breast Cancer Cell Lines. SHILAP Revista de lepidopterología. 28(168). 29–39. 1 indexed citations
7.
Chahardouli, Bahram, Saeed Mohammadi, Mohsen Nikbakht, et al.. (2018). Detection of R882 Mutations in DNMT3A Gene in Acute Myeloid Leukemia: A Method Comparison Study. 8(3). 172–179. 1 indexed citations
8.
Dorgalaleh, Akbar, et al.. (2018). Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients. Blood Coagulation & Fibrinolysis. 30(1). 24–28. 6 indexed citations
9.
10.
Naderi, Majid, Shadi Tabibian, Marzia Menegatti, et al.. (2016). Disseminated intravascular coagulation with positive D-dimer. Blood Coagulation & Fibrinolysis. 27(8). 933–935. 5 indexed citations
11.
Dorgalaleh, Akbar, Farhad Zaker, Shadi Tabibian, et al.. (2016). Spectrum of factor X gene mutations in Iranian patients with congenital factor X deficiency. Blood Coagulation & Fibrinolysis. 27(3). 324–327. 7 indexed citations
12.
Zaker, Farhad, et al.. (2015). The Effect Of -401CT And -401CT Polymorphisms Of GGH Gene On Methotrexate Serum Level And Toxicity In Iranian Children With Acute Lymphoblastic Leukemia (ALL) Under Treatment In Ali Asghar Hospital In Tehran. SHILAP Revista de lepidopterología.
13.
Bahoush, Gholamreza, et al.. (2014). Association of -24CT, 1249GA, and 3972CT ABCC2 Gene Polymorphisms with Methotrexate Serum Levels and Toxic Side Effects in Children with Acute Lymphoblastic Leukemia. Pediatric Hematology and Oncology. 31(2). 169–177. 23 indexed citations
14.
Naderi, Majid, Shadi Tabibian, Shaban Alizadeh, et al.. (2014). Congenital Factor V Deficiency: Comparison of the Severity of Clinical Presentations among Patients with Rare Bleeding Disorders. Acta Haematologica. 133(2). 148–154. 21 indexed citations
15.
Chahardouli, Bahram, Farhad Zaker, Seied Asadollah Mousavi, et al.. (2013). Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistance. Hematology. 18(3). 158–162. 17 indexed citations
16.
Marjani, Abdoljalal, et al.. (2012). Serum lipid profiles in acute myocardial infarction patients in Gorgan. Biomedical Research-tokyo. 23(1). 0. 5 indexed citations
17.
Sheikhi, Maryam, et al.. (2010). Assesment of FLT3-gene mutations among children with acute leukemia.. Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch. 19(4). 230–235. 1 indexed citations
18.
Safa, Majid, Ahmad Kazemi, Hamid Zand, et al.. (2009). Inhibitory role of cAMP on doxorubicin-induced apoptosis in pre-B ALL cells through dephosphorylation of p53 serine residues. APOPTOSIS. 15(2). 196–203. 23 indexed citations
19.
Zaker, Farhad, Alison May, & Alan K. Burnett. (2002). Key Regulatory Gene Expression in Erythroleukemia Differentiation. 6(4). 97–103.
20.
Zaker, Farhad, et al.. (1997). Oncogenic RAS genes impair erythroid differentiation of erythroleukaemia cells. Leukemia Research. 21(7). 635–640. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guanghua Zhu Breakdown of academic impact, for papers by Richard Coffey Breakdown of academic impact, for papers by Mohamed El‐Shanshory Breakdown of academic impact, for papers by Suzanne Monjanel‐Mouterde Breakdown of academic impact, for papers by Romélia Pinheiro Gonçalves Breakdown of academic impact, for papers by Maciej Niedźwiecki Breakdown of academic impact, for papers by Geetika Srivastava Breakdown of academic impact, for papers by Željka Večerić‐Haler Breakdown of academic impact, for papers by Han Zhu Breakdown of academic impact, for papers by P. David Sadowitz
Rankless by CCL
2026